Literature DB >> 16487104

Necrobiotic xanthogranuloma with paraproteinaemia.

S Flann1, E M Wain, S Halpern, V Andrews, S Whittaker.   

Abstract

Necrobiotic xanthogranuloma is a rare cutaneous condition that can be mistaken for atypical necrobiosis lipoidica. It has a strong association with a paraproteinaemia, which may progress to frank haematological malignancy. We describe four patients with variable cutaneous features, and their treatment response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487104     DOI: 10.1111/j.1365-2230.2005.02042.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  5 in total

1.  A Multicenter Cross-Sectional Study and Systematic Review of Necrobiotic Xanthogranuloma With Proposed Diagnostic Criteria.

Authors:  Caroline A Nelson; Connie S Zhong; David A Hashemi; Hovik J Ashchyan; Zoe Brown-Joel; Megan H Noe; Sotonye Imadojemu; Robert G Micheletti; Ruth Ann Vleugels; Karolyn A Wanat; Misha Rosenbach; Arash Mostaghimi
Journal:  JAMA Dermatol       Date:  2020-03-01       Impact factor: 10.282

2.  A 7-Year History of Necrobiotic Xanthogranuloma following Asymptomatic Multiple Myeloma: A Case Report.

Authors:  Siriluk Inthasotti; Rungsima Wanitphakdeedecha; Jane Manonukul
Journal:  Dermatol Res Pract       Date:  2011-04-10

3.  Necrobiotic Xanthogranuloma in a Patient with Multiple Myeloma.

Authors:  Marlies Wruhs; Robert Feldmann; Isabelle Sawetz; Friedrich Breier; Andreas Steiner
Journal:  Case Rep Dermatol       Date:  2016-12-01

4.  Miescher's granulomatosis (granulomatosis disciformis chronica et progressiva) in a non-diabetic patient--case report.

Authors:  Beata Bergler-Czop; Ligia Brzezińska-Wcisło; Iwona Rogala-Poborska
Journal:  Diagn Pathol       Date:  2009-08-28       Impact factor: 2.644

Review 5.  Systemic therapy of necrobiotic xanthogranuloma: a systematic review.

Authors:  Lisa Steinhelfer; Thomas Kühnel; Herbert Jägle; Stephanie Mayer; Sigrid Karrer; Frank Haubner; Stephan Schreml
Journal:  Orphanet J Rare Dis       Date:  2022-03-24       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.